a therapeutics company focusing on discovering and developing novel gene control therapies
Industry Biotechnology
A.I.dvisor indicates that over the last year, SYRS has been loosely correlated with XFOR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRS jumps, then XFOR could also see price increases.
Ticker / NAME | Correlation To SYRS | 1D Price Change % | ||
---|---|---|---|---|
SYRS | 100% | -5.74% | ||
XFOR - SYRS | 50% Loosely correlated | -1.59% | ||
ORMP - SYRS | 33% Poorly correlated | -4.50% | ||
CTXR - SYRS | 32% Poorly correlated | -39.10% | ||
KNTPF - SYRS | 32% Poorly correlated | N/A | ||
AXON - SYRS | 30% Poorly correlated | -0.86% | ||
More |